SPARTA Discovery’s analysis platform helps to speed up the development, manufacture, and quality control of nanoparticles for biopharmaceutical drugs. The SPARTA technology – Single Particle Automated Raman Trapping Analysis – uses spectroscopy to analyze populations of individual nanoparticles quickly and automatically at high throughput – helping to accelerate nanoparticle development and optimize quality control during production. Nanoparticles are small polymer or lipid capsules that act as carriers to deliver active agents to the target cells.

A team of Frankfurt, London and Birmingham-based lawyers provided legal advice to Sartorius group on all matters relating to the investment agreement.